Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3.
    Difference
    0.0%
    Check dated 2026-05-22T16:13:41.000Z thumbnail image
  2. Check
    17 days ago
    No Change Detected
  3. Check
    24 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page footer now shows an updated site revision number (from v3.5.2 to v3.5.3), indicating a new release of the ClinicalTrials.gov interface without altering the study information presented.
    Difference
    0.0%
    Check dated 2026-04-24T06:39:15.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:48:28.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The Publications section was updated to include the 2024 Blood article by Friedberg et al. on frontline brentuximab vedotin therapy for older HL patients ineligible for chemotherapy, and the Erratum for that Blood article was removed.
    Difference
    0.0%
    Check dated 2026-04-02T15:35:03.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page; this appears to be a maintenance/versioning update with no changes to study content.
    Difference
    0.0%
    Check dated 2026-03-19T04:59:05.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.3 instead of Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:49:36.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.